Department of Basic Neurosciences, Medical Faculty, University of Geneva, Geneva, Switzerland.
Trends Neurosci. 2011 Apr;34(4):188-97. doi: 10.1016/j.tins.2011.01.004. Epub 2011 Feb 25.
Benzodiazepines are widely used clinically to treat anxiety and insomnia. They also induce muscle relaxation, control epileptic seizures, and can produce amnesia. Moreover, benzodiazepines are often abused after chronic clinical treatment and also for recreational purposes. Within weeks, tolerance to the pharmacological effects can develop as a sign of dependence. In vulnerable individuals with compulsive drug use, addiction will be diagnosed. Here we review recent observations from animal models regarding the cellular and molecular basis that might underlie the addictive properties of benzodiazepines. These data reveal how benzodiazepines, acting through specific GABA(A) receptor subtypes, activate midbrain dopamine neurons, and how this could hijack the mesolimbic reward system. Such findings have important implications for the future design of benzodiazepines with reduced or even absent addiction liability.
苯二氮䓬类药物在临床上被广泛用于治疗焦虑和失眠。它们还能诱导肌肉松弛、控制癫痫发作,并产生健忘症。此外,苯二氮䓬类药物在慢性临床治疗后经常被滥用,也被用于娱乐目的。在数周内,对药物作用的耐受性会发展,这是一种依赖的迹象。在有强迫性药物使用的易受影响的个体中,将被诊断为成瘾。在这里,我们回顾了最近在动物模型中关于可能是苯二氮䓬类药物成瘾特性基础的细胞和分子基础的观察结果。这些数据揭示了苯二氮䓬类药物如何通过特定的 GABA(A) 受体亚型作用于中脑多巴胺神经元,以及这如何劫持中脑边缘奖励系统。这些发现对未来设计具有降低甚至消除成瘾性的苯二氮䓬类药物具有重要意义。